Richard Champlin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Wang Yang; Li Dan; Jones Dan; Bassett Roland; Sale George E; Khalili Jahan; Komanduri Krishna V; Couriel Daniel R; Champlin Richard E; Molldrem Jeffrey J; Ma Qing
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.
Nakayama Kazutaka; Liu Ping; Detry Michelle; Schover Leslie R; Milbourne Andrea; Neumann Joyce; Rondon Gabriela; Thewes Belinda; Champlin Richard E; Ueno Naoto T
Receiving information on fertility- and menopause-related treatment effects among women who undergo hematopoietic stem cell transplantation: changes in perceived importance over time.
Fenske Timothy S; Hari Parameswaran N; Carreras Jeanette; Zhang Mei-Jie; Kamble Rammurti T; Bolwell Brian J; Cairo Mitchell S; Champlin Richard E; Chen Yi-Bin; Freytes César O; Gale Robert Peter; Hale Gregory A; Ilhan Osman; Khoury H Jean; Lister John; Maharaj Dipnarine; Marks David I; Munker Reinhold; Pecora Andrew L; Rowlings Philip A; Shea Thomas C; Stiff Patrick; Wiernik Peter H; Winter Jane N; Rizzo J Douglas; van Besien Koen; Lazarus Hillard M; Vose Julie M
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Champlin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Wang Yang; Li Dan; Jones Dan; Bassett Roland; Sale George E; Khalili Jahan; Komanduri Krishna V; Couriel Daniel R; Champlin Richard E; Molldrem Jeffrey J; Ma Qing
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1513-22.
2009: Nakayama Kazutaka; Liu Ping; Detry Michelle; Schover Leslie R; Milbourne Andrea; Neumann Joyce; Rondon Gabriela; Thewes Belinda; Champlin Richard E; Ueno Naoto T
Receiving information on fertility- and menopause-related treatment effects among women who undergo hematopoietic stem cell transplantation: changes in perceived importance over time.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1465-74.
2009: Fenske Timothy S; Hari Parameswaran N; Carreras Jeanette; Zhang Mei-Jie; Kamble Rammurti T; Bolwell Brian J; Cairo Mitchell S; Champlin Richard E; Chen Yi-Bin; Freytes César O; Gale Robert Peter; Hale Gregory A; Ilhan Osman; Khoury H Jean; Lister John; Maharaj Dipnarine; Marks David I; Munker Reinhold; Pecora Andrew L; Rowlings Philip A; Shea Thomas C; Stiff Patrick; Wiernik Peter H; Winter Jane N; Rizzo J Douglas; van Besien Koen; Lazarus Hillard M; Vose Julie M
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1455-64.
2009: Ciurea Stefan O; de Lima Marcos; Cano Pedro; Korbling Martin; Giralt Sergio; Shpall Elizabeth J; Wang Xuemei; Thall Peter F; Champlin Richard E; Fernandez-Vina Marcelo
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
Transplantation 2009;88(8):1019-24.
2009: Qazilbash Muzaffar H; Amjad Ali Imran; Qureshi Suhail; Qureshi Sofia R; Saliba Rima M; Khan Ziad U; Hosing Chitra; Giralt Sergio A; De Lima Marcos J; Popat Uday R; Yusuf Syed W; Champlin Richard E
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1265-70.
2009: Parmar Simrit; Del Lima Marcos; Zou Yizhou; Patah Poliana A; Liu Ping; Cano Pedro; Rondon Gabriela; Pesoa Susana; de Padua Silva Leandro; Qazilbash Muzaffar H; Hosing Chitra; Popat Uday; Kebriaei Partow; Shpall Elizabeth J; Giralt Sergio; Champlin Richard E; Stastny Peter; Fernandez-Vina Marcelo
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
Blood 2009;114(14):2884-7.
2009: de Souza Jonas A; Saliba Rima M; Patah Poliana; Rondon Gabriela; Ribeiro Rachel; de Padua Silva Leandro; Qazilbash Muzaffar H; Hosing Chitra; Popat Uday; Efebera Yvonne; Champlin Richard E; de Lima Marcos
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1094-9.
2009: Ueno Naoto T; de Souza Jonas A; Booser Daniel; Nakayama Kazutaka; Madewell John; Wendt Richard E; Hortobagyi Gabriel N; Podoloff Donald; Champlin Richard E
Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer.
Clinical breast cancer 2009;9(3):173-7.
2009: Parikh Gaurav C; Amjad Ali Imran; Saliba Rima M; Kazmi Syed M A; Khan Ziad U; Lahoti Amit; Hosing Chitra; Mendoza Floralyn; Qureshi Suhail R; Weber Donna M; Wang Michael; Popat Uday; Alousi Amin M; Champlin Richard E; Giralt Sergio A; Qazilbash Muzaffar H
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):812-6.
2009: de Souza J A; Davis M L; Rondon G; Cheng Y C; Jones R B; Champlin R E; Ueno N T
Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer.
Bone marrow transplantation 2009;44(2):81-7.
2009: Andersson Borje S; de Lima Marcos; Thall Peter F; Madden Timothy; Russell James A; Champlin Richard E
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.
Current opinion in oncology 2009;21 Suppl 1():S11-5.
2009: Hosing Chitra; Saliba Rima M; Ahlawat Sheena; Körbling Martin; Kebriaei Partow; Alousi Amin; De Lima Marcos; Okoroji Julia-Grace; McMannis John; Qazilbash Muzaffar; Anderlini Paolo; Giralt Sergio; Champlin Richard E; Khouri Issa; Popat Uday
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
American journal of hematology 2009;84(6):335-7.
2009: Saliba R M; Komanduri K V; Giralt S; de Souza J; Patah P; Oran B; Couriel D; Rondon G; Champlin R E; de Lima M
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
Bone marrow transplantation 2009;43(9):685-92.
2009: Tam Constantine S; Bassett Roland; Ledesma Celina; Korbling Martin; Alousi Amin; Hosing Chitra; Kebraei Partow; Harrell Robyn; Rondon Gabriela; Giralt Sergio A; Anderlini Paolo; Popat Uday; Pro Barbara; Samuels Barry; Hagemeister Frederick; Medeiros L Jeffrey; Champlin Richard E; Khouri Issa F
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
Blood 2009;113(18):4144-52.
2009: Ramos Carlos A; Saliba Rima M; de Pádua Leandro; Khorshid Ola; Shpall Elizabeth J; Giralt Sergio; Patah Poliana A; Hosing Chitra M; Popat Uday R; Rondon Gabriela; Khouri Issa F; Nieto Yago L; Champlin Richard E; de Lima Marcos
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Haematologica 2009;94(2):249-57.
2008: Qazilbash Muzaffar H; Saliba Rima M; Nieto Yago; Parikh Gaurav; Pelosini Matteo; Khan Fatima B; Jones Roy B; Hosing Chitra; Mendoza Floralyn; Weber Donna M; Wang Michael; Popat Uday; Alousi Amin; Anderlini Paolo; Champlin Richard E; Giralt Sergio
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1401-7.
2008: Valdez Benigno C; Murray David; Ramdas Latha; de Lima Marcos; Jones Roy; Kornblau Steven; Betancourt Daniel; Li Yang; Champlin Richard E; Andersson Borje S
Altered gene expression in busulfan-resistant human myeloid leukemia.
Leukemia research 2008;32(11):1684-97.
2008: Tam Constantine S; Nussenzveig Roberto M; Popat Uday; Bueso-Ramos Carlos E; Thomas Deborah A; Cortes Jorge A; Champlin Richard E; Ciurea Stefan E; Manshouri Taghi; Pierce Sherry M; Kantarjian Hagop M; Verstovsek Srdan
The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms.
Blood 2008;112(5):1628-37.
2008: Alousi Amin M; Saliba Rima M; Okoroji Grace-Julia; Macapinlac Homer A; Hosing Chitra; Korbling Martin; Samuels Barry I; Popat Uday; Kebriaei Partow; Anderlini Paolo; Qazilbash Muzaffar H; de Lima Marcos; Giralt Sergio A; Champlin Richard E; Khouri Issa F
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
British journal of haematology 2008;142(5):786-92.
2008: Andersson Borje S; de Lima Marcos; Thall Peter F; Wang Xuemei; Couriel Daniel; Korbling Martin; Roberson Soonja; Giralt Sergio; Pierre Betty; Russell James A; Shpall Elizabeth J; Jones Roy B; Champlin Richard E
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):672-84.
2008: Khouri Issa F; McLaughlin Peter; Saliba Rima M; Hosing Chitra; Korbling Martin; Lee Ming S; Medeiros L Jeffrey; Fayad Luis; Samaniego Felipe; Alousi Amin; Anderlini Paolo; Couriel Daniel; de Lima Marcos; Giralt Sergio; Neelapu Sattva S; Ueno Naoto T; Samuels Barry I; Hagemeister Fredrick; Kwak Larry W; Champlin Richard E
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Blood 2008;111(12):5530-6.
2008: Hosing C; Saliba R M; Okoroji G-J; Popat U; Couriel D; Ali T; De Padua Silva L; Kebriaei P; Alousi A; De Lima M; Qazilbash M; Anderlini P; Giralt S; Champlin R E; Khouri I
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1166-71.
2008: Singh Harjeet; Manuri Pallavi R; Olivares Simon; Dara Navid; Dawson Margaret J; Huls Helen; Hackett Perry B; Kohn Donald B; Shpall Elizabeth J; Champlin Richard E; Cooper Laurence J N
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.
Cancer research 2008;68(8):2961-71.
2008: Koca Ebru; Champlin Richard E
Peripheral blood progenitor cell or bone marrow transplantation: controversy remains.
Current opinion in oncology 2008;20(2):220-6.
2008: Ueno N T; Rizzo J D; Demirer T; Cheng Y C; Hegenbart U; Zhang M-J; Bregni M; Carella A; Blaise D; Bashey A; Bitran J D; Bolwell B J; Elfenbein G J; Fields K K; Freytes C O; Gale R P; Lazarus H M; Champlin R E; Stiff P J; Niederwieser D
Allogeneic hematopoietic cell transplantation for metastatic breast cancer.
Bone marrow transplantation 2008;41(6):537-45.
2008: Nakayama Kazutaka; Milbourne Andrea; Schover Leslie R; Champlin Richard E; Ueno Naoto T
Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers.
Nature clinical practice. Oncology 2008;5(2):78-89.
2008: Anderlini Paolo; Saliba Rima; Acholonu Sandra; Giralt Sergio A; Andersson Borje; Ueno Naoto T; Hosing Chitra; Khouri Issa F; Couriel Daniel; de Lima Marcos; Qazilbash Muzaffar H; Pro Barbara; Romaguera Jorge; Fayad Luis; Hagemeister Frederick; Younes Anas; Munsell Mark F; Champlin Richard E
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
Haematologica 2008;93(2):257-64.
2008: de Lima M; Champlin R E; Thall P F; Wang X; Martin T G; Cook J D; McCormick G; Qazilbash M; Kebriaei P; Couriel D; Shpall E J; Khouri I; Anderlini P; Hosing C; Chan K W; Andersson B S; Patah P A; Caldera Z; Jabbour E; Giralt S
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(2):258-64.
2007: Chou Lillian S; Lewis Russell E; Ippoliti Cindy; Champlin Richard E; Kontoyiannis Dimitrios P
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Pharmacotherapy 2007;27(12):1644-50.
2007: Komanduri Krishna V; St John Lisa S; de Lima Marcos; McMannis John; Rosinski Steven; McNiece Ian; Bryan Susan G; Kaur Indreshpal; Martin Sean; Wieder Eric D; Worth Laura; Cooper Laurence J N; Petropoulos Demetrios; Molldrem Jeffrey J; Champlin Richard E; Shpall Elizabeth J
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.
Blood 2007;110(13):4543-51.
2007: Oran B; Giralt S; Couriel D; Hosing C; Shpall E J; de Meis E; Khouri I F; Qazilbash M; Anderlini P; Kebriaei P; Popat U; Carrasco-Yalan A; Champlin R E; de Lima M
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(12):2540-4.
2007: Safdar Amar; Rodriguez Gilhen H; De Lima Marcos J; Petropoulos Demetrios; Chemaly Roy F; Worth Laura L; Shpall Elizabeth J; Rolston Kenneth V I; Raad Issam I; Chan Ka Wah; Champlin Richard E
Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005.
Medicine 2007;86(6):324-33.
2007: Kebriaei Partow; Detry Michelle A; Giralt Sergio; Carrasco-Yalan Antonio; Anagnostopoulos Athanasios; Couriel Daniel; Khouri Issa F; Anderlini Paolo; Hosing Chitra; Alousi Amin; Champlin Richard E; de Lima Marcos
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
Blood 2007;110(9):3456-62.
2007: Qazilbash Muzaffar H; Saliba Rima M; Ahmed Bilal; Parikh Gaurav; Mendoza Floralyn; Ashraf Noman; Hosing Chitra; Flosser Thuy; Weber Donna M; Wang Michael; Couriel Daniel R; Popat Uday; Kebriaei Partow; Alousi Amin M; Anderlini Paolo; Naeem Rizwan C; Champlin Richard E; Giralt Sergio A
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1066-72.
2007: Jabbour E; Rondon G; Anderlini P; Giralt S A; Couriel D R; Champlin R E; Khouri I F
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
Bone marrow transplantation 2007;40(5):431-5.
2007: Nakayama Kazutaka; Tannir Nizar M; Liu Ping; Wathen Jay K; Cheng Yee Chung; Champlin Richard E; Ueno Naoto T
Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(8):975-85.
2007: Schrezenmeier Hubert; Passweg Jakob R; Marsh Judith C W; Bacigalupo Andrea; Bredeson Christopher N; Bullorsky Eduardo; Camitta Bruce M; Champlin Richard E; Gale Robert Peter; Fuhrer Monika; Klein John P; Locasciulli Anna; Oneto Rosi; Schattenberg Antonius V M B; Socie Gerard; Eapen Mary
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
Blood 2007;110(4):1397-400.
2007: Ozdemir E; Saliba R M; Champlin R E; Couriel D R; Giralt S A; de Lima M; Khouri I F; Hosing C; Kornblau S M; Anderlini P; Shpall E J; Qazilbash M H; Molldrem J J; Chemaly R F; Komanduri K V
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
Bone marrow transplantation 2007;40(2):125-36.
2007: Eapen Mary; Rubinstein Pablo; Zhang Mei-Jie; Stevens Cladd; Kurtzberg Joanne; Scaradavou Andromachi; Loberiza Fausto R; Champlin Richard E; Klein John P; Horowitz Mary M; Wagner John E
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.
Lancet 2007;369(9577):1947-54.
2007: Kornblau Steven M; Aycox Preston G; Stephens Clifton; McCue L David; Champlin Richard E; Marini Frank C
Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
Experimental hematology 2007;35(5):842-53.
2007: Khouri Issa F; Saliba Rima M; Admirand Joan; O'Brien Susan; Lee Ming-S; Korbling Martin; Samuels Barry I; Giralt Sergio; Lima de Marcos; Keating Michael J; Champlin Richard E; Bueso-Ramos Carlos
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.
British journal of haematology 2007;137(4):355-63.
2007: Champlin Richard E; Perez Waleska S; Passweg Jakob R; Klein John P; Camitta Bruce M; Gluckman Eliane; Bredeson Christopher N; Eapen Mary; Horowitz Mary M
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
Blood 2007;109(10):4582-5.
2007: Oran Betul; Donato Michele; Aleman Ana; Hosing Chitra; Korbling Martin; Detry Michelle A; Wei Caimiao; Anderlini Paolo; Popat Uday; Shpall Elizabeth; Giralt Sergio; Champlin Richard E
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):469-77.
2007: Oran Betul; Giralt Sergio; Saliba Rima; Hosing Chitra; Popat Uday; Khouri Issa; Couriel Daniel; Qazilbash Muzaffar; Anderlini Paolo; Kebriaei Partow; Ghosh Shubhra; Carrasco-Yalan Antonio; de Meis Ernesto; Anagnostopoulos Athanasios; Donato Michele; Champlin Richard E; de Lima Marcos
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):454-62.
2007: Saliba Rima M; de Lima Marcos; Giralt Sergio; Andersson Borje; Khouri Issa F; Hosing Chitra; Ghosh Shubhra; Neumann Joyce; Hsu Yvonne; De Jesus Jorge; Qazilbash Muzaffar H; Champlin Richard E; Couriel Daniel R
Hyperacute GVHD: risk factors, outcomes, and clinical implications.
Blood 2007;109(7):2751-8.
2007: Youssef Souad; Rodriguez Gilhen; Rolston Kenneth V; Champlin Richard E; Raad Issam I; Safdar Amar
Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005.
Medicine 2007;86(2):69-77.
2007: Qazilbash M H; Saliba R M; Hosing C; Mendoza F; Qureshi S R; Weber D M; Wang M; Flosser T; Couriel D R; De Lima M; Kebriaei P; Popat U; Alousi A M; Champlin R E; Giralt S A
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
Bone marrow transplantation 2007;39(5):279-83.
2007: Safdar A; Rodriguez G; Rolston K V I; O'Brien S; Khouri I F; Shpall E J; Keating M J; Kantarjian H M; Champlin R E; Raad I I; Kontoyiannis D P
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.
Bone marrow transplantation 2007;39(3):157-64.
2007: Madden Timothy; de Lima Marcos; Thapar Neil; Nguyen John; Roberson Soonja; Couriel Daniel; Pierre Betty; Shpall Elizabeth J; Jones Roy B; Champlin Richard E; Andersson Borje S
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(1):56-64.
2006: Schmitz Norbert; Eapen Mary; Horowitz Mary M; Zhang Mei-Jie; Klein John P; Rizzo J Douglas; Loberiza Fausto R; Gratwohl Alois; Champlin Richard E;
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Blood 2006;108(13):4288-90.
2006: Körbling Martin; Reuben James M; Gao Hui; Lee Bang-Ning; Harris David M; Cogdell David; Giralt Sergio A; Khouri Issa F; Saliba Rima M; Champlin Richard E; Zhang Wei; Estrov Zeev
Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.
Transfusion 2006;46(10):1795-802.
2006: Johnson Malisha R; Del Carpio-Jayo Daniel; Lin Pei; Giralt Sergio; Anderlini Paolo; Champlin Richard E; Khouri Issa F; Vadhan-Raj Saroj; Medeiros L Jeffrey; Bueso-Ramos Carlos E
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
Annals of diagnostic pathology 2006;10(5):263-8.
2006: Chemaly Roy F; Ghosh Shubhra; Bodey Gerald P; Rohatgi Nidhi; Safdar Amar; Keating Michael J; Champlin Richard E; Aguilera Elizabeth A; Tarrand Jeffrey J; Raad Issam I
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.
Medicine 2006;85(5):278-87.
2006: Lekakis L; Giralt S; Couriel D; Shpall E J; Hosing C; Khouri I F; Anderlini P; Korbling M; Martin T; Champlin R E; de Lima M
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Bone marrow transplantation 2006;38(6):421-6.
2006: Qazilbash M H; Ueno N T; Hosing C; De Lima M; Cortes J; Massaro A; Rivera Z; Deavers M; Adachi J A; Champlin R E
Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation.
Bone marrow transplantation 2006;38(5):393-4.
2006: Kebriaei P; Saliba R M; Ma C; Ippoliti C; Couriel D R; de Lima M; Giralt S; Qazilbash M H; Gajewski J L; Ha C S; Champlin R E; Khouri I F
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.
Bone marrow transplantation 2006;38(3):203-9.
2006: Qazilbash Muzaffar H; Saliba Rima M; Aleman Ana; Lei X; Weber Donna; Carrasco Antonio; Champlin Richard E; Giralt Sergio A
Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma.
Leukemia & lymphoma 2006;47(7):1360-4.
2006: Anderlini Paolo; Champlin Richard E
Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(6):599-602.
2006: Safdar Amar; Rodriguez Gilhen H; Lichtiger Benjamin; Dickey Burton F; Kontoyiannis Dimitrios P; Freireich Emil J; Shpall Elizabeth J; Raad Issam I; Kantarjian Hagop M; Champlin Richard E
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Cancer 2006;106(12):2664-71.
2006: Hosing Chitra; Qazilbash Muzaffar H; Kebriaei Partow; Giralt Sergio; Davis Marilyn S; Popat Uday; Anderlini Paolo; Shpall Elizabeth J; McMannis John; Körbling Martin; Champlin Richard E
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
British journal of haematology 2006;133(5):533-7.
2006: Hanrahan Emer O; Broglio Kristine; Frye Deborah; Buzdar Aman U; Theriault Richard L; Valero Vicente; Booser Daniel J; Singletary Sonja E; Strom Eric A; Gajewski James L; Champlin Richard E; Hortobagyi Gabriel N
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
Cancer 2006;106(11):2327-36.
2006: Ueno N T; Konoplev S; Buchholz T A; Smith T; Rondón G; Anderlini P; Giralt S A; Gajewski J L; Donato M L; Cristofanilli M; Champlin R E
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy.
Bone marrow transplantation 2006;37(10):929-35.
2006: Decker William K; Xing Dongxia; Li Sufang; Robinson Simon N; Yang Hong; Yao Xin; Segall Harry; McMannis John D; Komanduri Krishna V; Champlin Richard E; Shpall Elizabeth J
Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.
Vaccine 2006;24(16):3203-16.
2006: Yang H; Eaves C; de Lima M; Lee M S; Champlin R E; McMannis J D; Robinson S N; Niu T; Decker W K; Xing D; Ng J; Li S; Yao X; Eaves A C; Jones R; Andersson B S; Shpall E J
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
Bone marrow transplantation 2006;37(6):575-82.
2006: Khoury Hanna J; Loberiza Fausto R; Ringdén Olle; Barrett A John; Bolwell Brian J; Cahn Jean-Yves; Champlin Richard E; Gale Robert Peter; Hale Gregory A; Urbano-Ispizua Alvaro; Martino Rodrigo; McCarthy Philip L; Tiberghien Pierre; Verdonck Leo F; Horowitz Mary M
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.
Blood 2006;107(4):1712-6.
2006: Komanduri Krishna V; Couriel Daniel; Champlin Richard E
Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1 Suppl 2):1-6.
2006: Donato Michele L; Feasel Adrienne M; Weber Donna M; Prieto Victor G; Giralt Sergio A; Champlin Richard E; Duvic Madeleine
Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.
Blood 2006;107(2):463-6.
2006: Xing D; Decker W K; Li S; Robinson S N; Yang H; Segal H; O'Connor S; Yao X; Komanduri K V; McMannis J D; Jones R B; de Lima M; Champlin R E; Shpall E J
AML-loaded DC generate Th1-type cellular immune responses in vitro.
Cytotherapy 2006;8(2):95-104.
2005: Cheng Yee Chung; Saliba Rima M; Rondón Gabriela; Giralt Sergio A; Lu Karen H; Bodurka Diane C; Gershenson David M; Champlin Richard E; Ueno Naoto T
Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.
Haematologica 2005;90(12):1725-6.
2005: Hosing C; Saliba R M; Shahjahan M; Estey E H; Couriel D; Giralt S; Andersson B; Champlin R E; De Lima M
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.
Bone marrow transplantation 2005;36(2):157-62.
2005: Anderlini P; Saliba R; Acholonu S; Okoroji G-J; Donato M; Giralt S; Andersson B; Ueno N T; Khouri I; De Lima M; Hosing C; Cohen A; Ippoliti C; Romaguera J; Rodriguez M A; Pro B; Fayad L; Goy A; Younes A; Champlin R E
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen.
Bone marrow transplantation 2005;35(10):943-51.
2005: Khouri Issa F; Saliba Rima M; Hosing Chitra; Okoroji Grace-Julia; Acholonu Sandra; Anderlini Paolo; Couriel Daniel; De Lima Marcos; Donato Michele L; Fayad Luis; Giralt Segio; Jones Roy; Korbling Martin; Maadani Farzaneh; Manning John T; Pro Barbara; Shpall Elizabeth; Younes Anas; McLaughlin Peter; Champlin Richard E
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2240-7.
2005: Safdar Amar; Rodriguez Gilhen; Ohmagari Norio; Kontoyiannis Dimitrios P; Rolston Kenneth V; Raad Issam I; Champlin Richard E
The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation.
Cancer 2005;103(4):731-9.
2004: Khorshid Ola; Hosing Chitra; Bibawi Samer; Ueno Naoto; Reveille John; Mayes Maureen D; Champlin Richard E
Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus.
The Journal of rheumatology 2004;31(12):2513-6.
2004: Eapen Mary; Horowitz Mary M; Klein John P; Champlin Richard E; Loberiza Fausto R; Ringdén Olle; Wagner John E
Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4872-80.
2004: Martins Sergio L R; St John Lisa S; Champlin Richard E; Wieder Eric D; McMannis John; Molldrem Jeffrey J; Komanduri Krishna V
Functional assessment and specific depletion of alloreactive human T cells using flow cytometry.
Blood 2004;104(12):3429-36.
2004: Laughlin Mary J; Eapen Mary; Rubinstein Pablo; Wagner John E; Zhang Mei-Jei; Champlin Richard E; Stevens Cladd; Barker Juliet N; Gale Robert P; Lazarus Hillard M; Marks David I; van Rood Jon J; Scaradavou Andromachi; Horowitz Mary M
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
The New England journal of medicine 2004;351(22):2265-75.
2004: Studeny Matus; Marini Frank C; Dembinski Jennifer L; Zompetta Claudia; Cabreira-Hansen Maria; Bekele Benjamin Nebiyou; Champlin Richard E; Andreeff Michael
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
Journal of the National Cancer Institute 2004;96(21):1593-603.
2004: Cheng Yee Chung; Rondón Gabriela; Yang Ying; Smith Terry L; Gajewski James L; Donato Michele L; Shpall Elizabeth J; Jones Roy; Hortobagyi Gabriel N; Champlin Richard E; Ueno Naoto T
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(11):794-804.
2004: Eapen M; Giralt S A; Horowitz M M; Klein J P; Wagner J E; Zhang M-J; Tallman M S; Marks D I; Camitta B M; Champlin R E; Ringdén O; Bredeson C N; Martino R; Gale R P; Cairo M S; Litzow M R; deLima M
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
Bone marrow transplantation 2004;34(8):721-7.
2004: Anderlini P; Acholonu S A; Okoroji G-J; Andersson B S; Couriel D R; De Lima M J; Donato M L; Khouri I F; Giralt S A; Ueno N T; Champlin R E
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response.
Bone marrow transplantation 2004;34(6):511-4.
2004: Jabbour E; Keating M J; Champlin R E; Khouri I F
Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?
Bone marrow transplantation 2004;34(4):289-97.
2004: de Lima Marcos; Couriel Daniel; Thall Peter F; Wang Xuemei; Madden Timothy; Jones Roy; Shpall Elizabeth J; Shahjahan Munir; Pierre Betty; Giralt Sergio; Korbling Martin; Russell James A; Champlin Richard E; Andersson Borje S
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
Blood 2004;104(3):857-64.
2004: Gajewski James L; Foote Mary; Tietjen John; Melson Ben; Simmons Angela; Champlin Richard E
Blood and marrow transplantation compensation: perspective in payer and provider relations.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(7):427-32.
2004: Qazilbash Muzaffar H; Giralt Sergio A; Champlin Richard E
Nonmyeloablative stem cell transplantation for chronic myeloid leukemia.
Hematology/oncology clinics of North America 2004;18(3):703-13, xi.
2004: Escalón Maricer P; Champlin Richard E; Saliba Rima M; Acholonu Sandra A; Hosing Chitra; Fayad Luis; Giralt Sergio; Ueno Naoto T; Maadani Farzaneh; Pro Barbara; Donato Michele; McLaughlin Peter; Khouri Issa F
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2419-23.
2004: Donato M L; Aleman A; Champlin R E; Saliba R M; Wharton J T; Burke T W; Bodurka D C; Bevers M W; Levenback C F; Wolf J K; Bast R C; Freedman R S; Ippoliti C; Brewer M; Gajewski J L; Gershenson D M
Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation.
Bone marrow transplantation 2004;33(12):1219-24.
2004: Popat U; Hosing C; Saliba R M; Anderlini P; van Besien K; Przepiorka D; Khouri I F; Gajewski J; Claxton D; Giralt S; Rodriguez M; Romaguera J; Hagemeister F; Ha C; Cox J; Cabanillas F; Andersson B S; Champlin R E
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;33(10):1015-23.
2004: Mittal P; Saliba R M; Giralt S A; Shahjahan M; Cohen A I; Karandish S; Onida F; Beran M; Champlin R E; de Lima M
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Bone marrow transplantation 2004;33(10):1005-9.
2004: Donato Michele L; Aleman Ana; Champlin Richard E; Weber Donna; Alexanian Raymond; Ippoliti Cindy M; de Lima Marcos; Anagnostopoulos Athanasios; Giralt Sergio
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma.
Leukemia & lymphoma 2004;45(4):755-9.
2004: Khouri I F; Albitar M; Saliba R M; Ippoliti C; Ma Y C; Keating M J; Champlin R E
Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics.
Bone marrow transplantation 2004;33(8):833-7.
2004: Khouri Issa F; Champlin Richard E
Nonmyeloablative stem cell transplantation for lymphoma.
Seminars in oncology 2004;31(1):22-6.
2004: Stanzani Marta; Martins Sergio L R; Saliba Rima M; St John Lisa S; Bryan Susan; Couriel Daniel; McMannis John; Champlin Richard E; Molldrem Jeffrey J; Komanduri Krishna V
CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.
Blood 2004;103(3):1140-6.
2004: Donato Michele L; Levenback Charles; Gershenson David M; McMeekin Scott; Champlin Richard E
Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report.
Gynecologic oncology 2004;92(1):365-7.
2004: Khouri Issa F; Lee Ming-Sheng; Saliba Rima M; Andersson Borje; Anderlini Paolo; Couriel Daniel; Hosing Chitra; Giralt Sergio; Korbling Martin; McMannis John; Keating Michael J; Champlin Richard E
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.
Experimental hematology 2004;32(1):28-35.
2004: Pentz Rebecca D; Chan Ka Wah; Neumann Joyce L; Champlin Richard E; Korbling Martin
Designing an ethical policy for bone marrow donation by minors and others lacking capacity.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 2004;13(2):149-55.
2003: Khouri Issa F; Saliba Rima M; Okoroji Grace-Julia; Acholonu Sandra A; Champlin Richard E
Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score.
Cancer 2003;98(12):2630-5.
2003: Khouri Issa F; Lee Ming-S; Saliba Rima M; Jun Gu; Fayad Luis; Younes Anas; Pro Barbara; Acholonu Sandra; McLaughlin Peter; Katz Ruth L; Champlin Richard E
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4407-12.
2003: Wu Hillary H; Talpaz Moshe; Champlin Richard E; Pilat Susan R; Kurzrock Razelle
Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
Cancer 2003;98(11):2410-9.
2003: Andersson Borje S; Kashyap Ashwin; Couriel Daniel; Madden Thomas; de Lima Marcos; Thall Peter F; Fernandez Hugo; Vaughan William P; Jones Roy; Wingard John R; Blume Karl G; Champlin Richard E
Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(11):722-4.
2003: Ueno Naoto T; Cheng Yee Chung; Rondón Gabriela; Tannir Nizar M; Gajewski James L; Couriel Daniel R; Hosing Chitra; de Lima Marcos J; Anderlini Paolo; Khouri Issa F; Booser Daniel J; Hortobagyi Gabriel N; Pagliaro Lance C; Jonasch Eric; Giralt Sergio A; Champlin Richard E
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
Blood 2003;102(10):3829-36.
2003: Hong David S; Jacobson Kalen L; Raad Issam I; de Lima Marcos; Anderlini Paolo; Fuller Gregory N; Ippoliti Cindy; Cool Rita M; Leeds Norman E; Narvios Aida; Han Xiang Y; Padula Anthony; Champlin Richard E; Hosing Chitra
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(8):1044-9.
2003: Wong Raymond; Giralt Sergio A; Martin Thomas; Couriel Daniel R; Anagnostopoulos Athanasios; Hosing Chitra; Andersson Borje S; Cano Pedro; Shahjahan Munir; Ippoliti Cindy; Estey Elihu H; McMannis John; Gajewski James L; Champlin Richard E; de Lima Marcos
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.
Blood 2003;102(8):3052-9.
2003: Champlin Richard E; Kantarjian Hagop
Current evaluation of imatinib and allogeneic transplant in the treatment of chronic myeloid leukemia.
Clinical advances in hematology & oncology : H&O 2003;1(7):398-400.
2003: Wong R; Rondon G; Saliba R M; Shannon V R; Giralt S A; Champlin R E; Ueno N T
Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
Bone marrow transplantation 2003;31(12):1157-63.
2003: Montemurro Filippo; Rondón Gabriela; Munsell Mark; Smith Terry L; Donato Michele L; Gajewski James L; Rahman Zia U; Buzdar Aman U; Champlin Richard E; Ueno Naoto T
Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(5):330-40.
2003: Hosing C; Saliba R M; McLaughlin P; Andersson B; Rodriguez M A; Fayad L; Cabanillas F; Champlin R E; Khouri I F
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(5):737-44.
2003: Thall Peter F; Wathen J Kyle; Bekele B Nebiyou; Champlin Richard E; Baker Laurence H; Benjamin Robert S
Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes.
Statistics in medicine 2003;22(5):763-80.
2002: Anderlini P; Chan F A; Champlin R E; Körbling M; Strom S S
Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development.
Bone marrow transplantation 2002;30(10):661-3.
2002: Ozdemir Evren; St John Lisa S; Gillespie Geraldine; Rowland-Jones Sarah; Champlin Richard E; Molldrem Jeffrey J; Komanduri Krishna V
Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells.
Blood 2002;100(10):3690-7.
2002: Ueno Naoto T; Anagnostopoulos Athanasios; Rondón Gabriela; Champlin Richard E; Mikhailova N; Pankratova O S; Zoubarovskaya L S; Semenova E V; Afanasyev B V; O'Brien Susan; Andreeff Michael; Zaritskey Andrey Y
Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome.
British journal of haematology 2002;119(1):131-4.
2002: Sierra Jorge; Pérez Waleska S; Rozman Ciril; Carreras Enric; Klein John P; Rizzo J Douglas; Davies Stella M; Lazarus Hillard M; Bredeson Christopher N; Marks David I; Canals Carmen; Boogaerts Marc A; Goldman John; Champlin Richard E; Keating Armand; Weisdorf Daniel J; de Witte Theo M; Horowitz Mary M
Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.
Blood 2002;100(6):1997-2004.
2002: Studeny Matus; Marini Frank C; Champlin Richard E; Zompetta Claudia; Fidler Isaiah J; Andreeff Michael
Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.
Cancer research 2002;62(13):3603-8.
2002: Montemurro F; Rondón G; Ueno N T; Munsell M; Gajewski J L; Champlin R E
Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.
Bone marrow transplantation 2002;29(10):861-6.
2002: Hosing C; Munsell M; Yazji S; Andersson B; Couriel D; de Lima M; Donato M; Gajewski J; Giralt S; Körbling M; Martin T; Ueno N T; Champlin R E; Khouri I F
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(3):450-9.
2002: Körbling Martin; Katz Ruth L; Khanna Abha; Ruifrok Arnout C; Rondon Gabriela; Albitar Maher; Champlin Richard E; Estrov Zeev
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
The New England journal of medicine 2002;346(10):738-46.
2002: McMannis J D; Champlin R E
Role of the GMP facility for adoptive immunotherapy.
Cytotherapy 2002;4(4):329-31.
2002: Andersson Borje S; Thall Peter F; Madden Timothy; Couriel Daniel; Wang Xuemei; Tran Hai T; Anderlini Paolo; de Lima Marcos; Gajewski James; Champlin Richard E
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):477-85.
2002: Hosing C; Champlin R E
The choice of allogeneic or autologous hematopoietic transplantation for NHL.
Cytotherapy 2002;4(3):259-69.
2002: Khouri I F; Keating M J; Saliba R M; Champlin R E
Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation.
Cytotherapy 2002;4(3):217-21.
2002: Andersson Borje S; Kashyap Ashwin; Gian Victor; Wingard John R; Fernandez Hugo; Cagnoni Pablo J; Jones Roy B; Tarantolo Stefano; Hu Wendy W; Blume Karl G; Forman Stephen J; Champlin Richard E
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):145-54.
2001: Kim Y S; Konoplev S N; Montemurro F; Hoy E; Smith T L; Rondón G; Champlin R E; Sahin A A; Ueno N T
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4008-12.
2001: Khouri I F; Saliba R M; Giralt S A; Lee M S; Okoroji G J; Hagemeister F B; Korbling M; Younes A; Ippoliti C; Gajewski J L; McLaughlin P; Anderlini P; Donato M L; Cabanillas F F; Champlin R E
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Blood 2001;98(13):3595-9.
2001: Gopal R; Ha C S; Tucker S L; Khouri I F; Giralt S A; Gajewski J L; Andersson B S; Cox J D; Champlin R E
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
Cancer 2001;92(7):1949-58.
2001: Rodriguez J; Munsell M; Yazji S; Hagemeister F B; Younes A; Andersson B; Giralt S; Gajewski J; de Lima M; Couriel D; Romaguera J; Cabanillas F F; Champlin R E; Khouri I F
Impact of high-dose chemotherapy on peripheral T-cell lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3766-70.
2001: Donato M L; Gershenson D M; Wharton J T; Ippoliti C M; Aleman A S; Bodurka-Bevers D; Bevers M W; Burke T W; Levenback C F; Wolf J K; Freedman R S; Bast R C; Gajewski J L; Champlin R E
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer.
Gynecologic oncology 2001;82(3):420-6.
2001: Ghosh S; Champlin R E; Ueno N T; Anderlini P; Rolston K; Raad I; Kontoyiannis D; Jacobson K; Luna M; Tarrand J; Whimbey E
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.
Bone marrow transplantation 2001;28(3):271-5.
2001: Konoplev S; Champlin R E; Giralt S; Ueno N T; Khouri I; Raad I; Rolston K; Jacobson K; Tarrand J; Luna M; Nguyen Q; Whimbey E
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients.
Bone marrow transplantation 2001;27(8):877-81.
2001: Anderlini P; Rizzo J D; Nugent M L; Schmitz N; Champlin R E; Horowitz M M;
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases.
Bone marrow transplantation 2001;27(7):689-92.
2001: La Rosa A M; Champlin R E; Mirza N; Gajewski J; Giralt S; Rolston K V; Raad I; Jacobson K; Kontoyiannis D; Elting L; Whimbey E
Adenovirus infections in adult recipients of blood and marrow transplants.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(6):871-6.
2001: Champlin R E; Whimbey E
Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7 Suppl():8S-10S.
2000: Montemurro F; Ueno N T; Rondón G; Aglietta M; Champlin R E
High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends.
Clinical breast cancer 2000;1(3):197-209; discussion 210.
2000: Rodriguez J; Keating M J; O'Brien S; Champlin R E; Khouri I F
Allogeneic haematopoietic transplantation for Richter's syndrome.
British journal of haematology 2000;110(4):897-9.
2000: Anderlini P; Giralt S; Andersson B; Ueno N T; Khouri I; Acholonu S; Cohen A; Körbling M J; Manning J; Romaguera J; Sarris A; Rodriguez; Hagemeister F; Mclaughlin P; Cabanillas F; Champlin R E
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
Bone marrow transplantation 2000;26(6):615-20.
2000: Molldrem J J; Lee P P; Wang C; Felio K; Kantarjian H M; Champlin R E; Davis M M
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.
Nature medicine 2000;6(9):1018-23.
2000: Anderlini P; Donato M; Lauppe M J; Huh Y O; Martin T G; Chan K W; Champlin R E; Körbling M
A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors.
British journal of haematology 2000;109(4):770-2.
2000: Donato M L; Gershenson D; Ippoliti C; Wharton J T; Bast R C; Aleman A; Anderlini P; Gajewski J G; Giralt S; Molldrem J; Ueno N; Lauppe J; Korbling M; Boyer J; Bodurka-Bevers D; Bevers M; Burke T; Freedman R; Levenback C; Wolf J; Champlin R E
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.
Bone marrow transplantation 2000;25(11):1137-40.
2000: Champlin R E; Passweg J R; Zhang M J; Rowlings P A; Pelz C J; Atkinson K A; Barrett A J; Cahn J Y; Drobyski W R; Gale R P; Goldman J M; Gratwohl A; Gordon-Smith E C; Henslee-Downey P J; Herzig R H; Klein J P; Marmont A M; O'Reilly R J; Ringdén O; Slavin S; Sobocinski K A; Speck B; Weiner R S; Horowitz M M
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
Blood 2000;95(12):3996-4003.
2000: Champlin R E; Schmitz N; Horowitz M M; Chapuis B; Chopra R; Cornelissen J J; Gale R P; Goldman J M; Loberiza F R; Hertenstein B; Klein J P; Montserrat E; Zhang M J; Ringdén O; Tomany S C; Rowlings P A; Van Hoef M E; Gratwohl A
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
Blood 2000;95(12):3702-9.
2000: Andersson B S; Gajewski J; Donato M; Giralt S; Gian V; Wingard J; Tarantolo S; Fernandez H; Hu W W; Blume K; Kashyap A; Forman S J; Champlin R E
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy).
Bone marrow transplantation 2000;25 Suppl 2():S35-8.
2000: Huaringa A J; Leyva F J; Signes-Costa J; Morice R C; Raad I; Darwish A A; Champlin R E
Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients.
Bone marrow transplantation 2000;25(9):975-9.
2000: Seong C M; Giralt S; Kantarjian H; Xu J; Swantkowski J; Hayes K; Glassman A B; Khouri I; Korbling M; Thall P; Siciliano M J; Champlin R E
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1831-6.
2000: Huaringa A J; Leyva F J; Giralt S A; Blanco J; Signes-Costa J; Velarde H; Champlin R E
Outcome of bone marrow transplantation patients requiring mechanical ventilation.
Critical care medicine 2000;28(4):1014-7.
2000: Ghosh S; Champlin R E; Englund J; Giralt S A; Rolston K; Raad I; Jacobson K; Neumann J; Ippoliti C; Mallik S; Whimbey E
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.
Bone marrow transplantation 2000;25(7):751-5.
2000: Hortobagyi G N; Buzdar A U; Theriault R L; Valero V; Frye D; Booser D J; Holmes F A; Giralt S; Khouri I; Andersson B; Gajewski J L; Rondon G; Smith T L; Singletary S E; Ames F C; Sneige N; Strom E A; McNeese M D; Deisseroth A B; Champlin R E
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
Journal of the National Cancer Institute 2000;92(3):225-33.
2000: Andersson B S; Madden T; Tran H T; Hu W W; Blume K G; Chow D S; Champlin R E; Vaughan W P
Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(5A):548-54.
2000: Donato M L; Champlin R E; Wharton J T; Bodurka-Bevers D; Gershenson D
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer.
European journal of gynaecological oncology 2000;21(3):241-4.
1999: Donato M L; Champlin R E; Van Besien K W; Korbling M; Cabanillas F; Anderlini P; Gajewski J G; Lauppe J; Durett A; Andersson B; Giralt S; Khouri I; Hagemeister F; Romaguera J E; Sarris A; McLaughlin P; Younes A; Ippoliti C; Blamble D A; Hester J; Gee A; Rodriguez M A
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
1999: Anderlini P; Donato M; Chan K W; Huh Y O; Gee A P; Lauppe M J; Champlin R E; Körbling M
Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
Transfusion 1999;39(6):555-60.
1999: Molldrem J J; Lee P P; Wang C; Champlin R E; Davis M M
A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia.
Cancer research 1999;59(11):2675-81.
1999: Choudhury B A; Liang J C; Thomas E K; Flores-Romo L; Xie Q S; Agusala K; Sutaria S; Sinha I; Champlin R E; Claxton D F
Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses.
Blood 1999;93(3):780-6.
1999: Garderet L; Snell V; Przepiorka D; Schenk T; Lu J G; Marini F; Gluckman E; Andreeff M; Champlin R E
Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations.
Transplantation 1999;67(1):124-30.
1998: Ueno N T; Rondón G; Mirza N Q; Geisler D K; Anderlini P; Giralt S A; Andersson B S; Claxton D F; Gajewski J L; Khouri I F; Körbling M; Mehra R C; Przepiorka D; Rahman Z; Samuels B I; van Besien K; Hortobagyi G N; Champlin R E
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):986-93.
1998: Bojko P; Hester J P; Durett A G; Maadani F; Körbling M; Champlin R E
Identification of megakaryocyte precursors in peripheral blood stem cell collections from normal donors.
Journal of clinical apheresis 1998;13(1):7-15.
1998: Choudhury A; Toubert A; Sutaria S; Charron D; Champlin R E; Claxton D F
Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity.
Critical reviews in immunology 1998;18(1-2):121-31.
1997: Zhang M J; Baccarani M; Gale R P; McGlave P B; Atkinson K; Champlin R E; Dicke K A; Giralt S; Gluckman E; Goldman J M; Klein J P; Herzig R H; Masaoka T; O'Reilly R J; Rozman C; Rowlings P A; Sobocinski K A; Speck B; Zwaan F E; Horowitz M M
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy.
British journal of haematology 1997;99(1):23-9.
1997: Rahman Z U; Frye D K; Buzdar A U; Smith T L; Asmar L; Champlin R E; Hortobagyi G N
Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3171-7.
1997: Passweg J R; Socié G; Hinterberger W; Bacigalupo A; Biggs J C; Camitta B M; Champlin R E; Gale R P; Gluckman E; Gordon-Smith E C; Hows J M; Klein J P; Nugent M L; Pasquini R; Rowlings P A; Speck B; Tichelli A; Zhang M J; Horowitz M M; Bortin M M
Bone marrow transplantation for severe aplastic anemia: has outcome improved?
Blood 1997;90(2):858-64.
1997: van Besien K W; de Lima M; Giralt S A; Moore D F; Khouri I F; Rondón G; Mehra R; Andersson B S; Dyer C; Cleary K; Przepiorka D; Gajewski J L; Champlin R E
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
Bone marrow transplantation 1997;19(10):977-82.
1997: Khouri I F; Przepiorka D; van Besien K; O'Brien S; Palmer J L; Lerner S; Mehra R C; Vriesendorp H M; Andersson B S; Giralt S; Körbling M; Keating M J; Champlin R E
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease.
British journal of haematology 1997;97(2):466-73.
1997: Johansen M J; Madden T; Mehra R C; Wood J G; Rondon G; Browne V; Newman R A; Champlin R E
Phase I pharmacokinetic study of multicycle high-dose carboplatin followed by peripheral-blood stem-cell infusion in patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1481-91.
1997: Choudhury A; Gajewski J L; Liang J C; Popat U; Claxton D F; Kliche K O; Andreeff M; Champlin R E
Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.
Blood 1997;89(4):1133-42.
1997: de Lima M; van Besien K W; Giralt S A; Khouri I F; Mehra R; Andersson B S; Przepiorka D; Gajewski J L; Korbling M; Champlin R E
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
Bone marrow transplantation 1997;19(2):121-7.
1996: Gale R P; Büchner T; Zhang M J; Heinecke A; Champlin R E; Dicke K A; Gluckman E; Good R A; Gratwohl A; Herzig R H; Keating A; Klein J P; Marmont A M; Prentice H G; Rowlings P A; Sobocinski K A; Speck B; Weiner R S; Horowitz M M
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(11):1687-91.
1996: Khouri I F; Ippoliti C; Gajewski J; Przepiorka D; Champlin R E
Neutropenias following allogeneic bone marrow transplantation: response to therapy with high-dose intravenous immunoglobulin.
American journal of hematology 1996;52(4):313-5.
1996: Khouri I F; Kantarjian H M; Talpaz M; Giralt S; Rios M O; Hester J P; Champlin R E; Deisseroth A B
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience.
Bone marrow transplantation 1996;17(5):775-9.
1996: Whimbey E; Champlin R E; Couch R B; Englund J A; Goodrich J M; Raad I; Przepiorka D; Lewis V A; Mirza N; Yousuf H; Tarrand J J; Bodey G P
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(5):778-82.
1996: Gajewski J L; Phillips G L; Sobocinski K A; Armitage J O; Gale R P; Champlin R E; Herzig R H; Hurd D D; Jagannath S; Klein J P; Lazarus H M; McCarthy P L; Pavlovsky S; Peterson F B; Rowlings P A; Russell J A; Silver S M; Vose J M; Wiernik P H; Bortin M M; Horowitz M M
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):572-8.
1996: Gale R P; Horowitz M M; Rees J K; Gray R G; Oken M M; Estey E H; Kim K M; Zhang M J; Ash R C; Atkinson K; Champlin R E; Dicke K A; Gajewski J L; Goldman J M; Helbig W; Henslee-Downey P S; Hinterberger W; Jacobsen N; Keating A; Klein J P; Marmont A M; Prentice H G; Reiffers J; Rimm A A; Bortin M M
Chemotherapy versus transplants for acute myelogenous leukemia in second remission.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(1):13-9.
1995: Przepiorka D; Chan K W; Champlin R E; Culbert S J; Petropoulos D; Ippoliti C; Khouri I; Huh Y O; Vreisendorp H; Deisseroth A B
Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
Bone marrow transplantation 1995;16(6):737-41.
1995: Gluckman E; Auerbach A D; Horowitz M M; Sobocinski K A; Ash R C; Bortin M M; Butturini A; Camitta B M; Champlin R E; Friedrich W; Good R A; Gordon-Smith E C; Harris R E; Klein J P; Ortega J J; Pasquini R; Ramsay N K; Speck B; Vowels M R; Zhang M J; Gale R P
Bone marrow transplantation for Fanconi anemia.
Blood 1995;86(7):2856-62.
1995: Körbling M; Huh Y O; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth A B; Champlin R E
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Blood 1995;86(7):2842-8.
1995: Whimbey E; Champlin R E; Englund J A; Mirza N Q; Piedra P A; Goodrich J M; Przepiorka D; Luna M A; Morice R C; Neumann J L
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
Bone marrow transplantation 1995;16(3):393-9.
1995: Seong D C; Kantarjian H M; Ro J Y; Talpaz M; Xu J; Robinson J R; Deisseroth A B; Champlin R E; Siciliano M J
Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment.
Blood 1995;86(6):2343-9.
1995: Korbling M; Przepiorka D; Gajewski J; Champlin R E; Chan K W
With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially?
Blood 1995;86(3):1235.
1995: Hester J P; Rondón G; Huh Y O; Lauppe M J; Champlin R E; Deisseroth A B
Principles of bone marrow processing and progenitor cell/mononuclear cell concentrate collection in a continuous flow blood cell separation system.
Journal of hematotherapy 1995;4(4):299-306.
1994: Giralt S A; Champlin R E
Leukemia relapse after allogeneic bone marrow transplantation: a review.
Blood 1994;84(11):3603-12.
1994: Seymour J F; Khouri I F; Champlin R E; Keating M J
Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review.
American journal of clinical oncology 1994;17(4):360-8.
1994: Guo J Q; Lian J Y; Xian Y M; Lee M S; Deisseroth A B; Stass S A; Champlin R E; Talpaz M; Wang J Y; Arlinghaus R B
BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy.
Blood 1994;83(12):3629-37.
1994: Körbling M; Drach J; Champlin R E; Engel H; Huynh L; Kleine H D; Berenson R; Deisseroth A B; Andreeff M
Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantation.
Bone marrow transplantation 1994;13(5):649-54.
1994: Seong D C; Song M Y; Henske E P; Zimmerman S O; Champlin R E; Deisseroth A B; Siciliano M J
Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid.
Blood 1994;83(8):2268-73.
1994: Meyers C A; Weitzner M; Byrne K; Valentine A; Champlin R E; Przepiorka D
Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):820-6.
1994: Gale R P; Horowitz M M; Ash R C; Champlin R E; Goldman J M; Rimm A A; Ringdén O; Stone J A; Bortin M M
Identical-twin bone marrow transplants for leukemia.
Annals of internal medicine 1994;120(8):646-52.
1994: Whimbey E; Elting L S; Couch R B; Lo W; Williams L; Champlin R E; Bodey G P
Influenza A virus infections among hospitalized adult bone marrow transplant recipients.
Bone marrow transplantation 1994;13(4):437-40.
1994: Przepiorka D; Dimopoulos M; Smith T; Ippoliti C; Diener K; Luna M; Champlin R E
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity.
Annals of hematology 1994;68(4):183-8.
1994: Przepiorka D; LeMaistre C F; Huh Y O; Luna M; Saria E A; Brown C T; Champlin R E
Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation.
Therapeutic immunology 1994;1(2):77-82.
1994: Przepiorka D; Huh Y O; Khouri I; Reading C; Hester J; Marshall M; Champlin R E
Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
Progress in clinical and biological research 1994;389():557-63.
1993: Anaissie E J; Kontoyiannis D P; Vartivarian S; Kantarjian H M; O'Brien S; Giralt S A; Andersson B S; Karl C; Champlin R E; Bodey G P
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(6):1022-31.
1993: Whimbey E; Vartivarian S E; Champlin R E; Elting L S; Luna M; Bodey G P
Parainfluenza virus infection in adult bone marrow transplant recipients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(9):699-701.
1993: Ippoliti C; Przepiorka D; Smith T; Maiese S; Giralt S; Andersson B S; Deisseroth A B; Champlin R E
Adverse effects of molgramostim in marrow transplant recipients.
Clinical pharmacy 1993;12(7):520-5.
1993: Giralt S A; Kantarjian H M; Talpaz M; Rios M B; Del Giglio A; Andersson B S; Przepiorka D; Deisseroth A B; Champlin R E
Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1055-61.
1993: Seong D C; Przepiorka D; Bruner J M; Van Tassel P; Lo W K; Champlin R E
Leptomeningeal toxoplasmosis after allogeneic marrow transplantation. Case report and review of the literature.
American journal of clinical oncology 1993;16(2):105-8.
1993: Ringdén O; Horowitz M M; Sondel P; Gale R P; Biggs J C; Champlin R E; Deeg H J; Dicke K; Masaoka T; Powles R L
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
Blood 1993;81(4):1094-101.
1993: Ippoliti C; Przepiorka D; Giralt S; Andersson B S; Wallerstein R O; Gutterman J; Deisseroth A B; Champlin R E
Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
Bone marrow transplantation 1993;11(1):55-9.
1993: Guo J Q; Hirsch-Ginsberg C F; Xian Y M; Stass S A; Champlin R E; Giralt S A; McCredie K B; Campbell M L; Arlinghaus R B
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Hematologic pathology 1993;7(2):91-106.
1992: Przepiorka D; Giralt S; Huh Y O; Andreeff M; Luna M; Reading C; Thomas M; Champlin R E
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
Transplantation proceedings 1992;24(6):2906-7.
1992: Horowitz M M; Przepiorka D; Champlin R E; Gale R P; Gratwohl A; Herzig R H; Prentice H G; Rimm A A; Ringdén O; Bortin M M
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?
Blood 1992;79(10):2771-4.
1992: Gluckman E; Horowitz M M; Champlin R E; Hows J M; Bacigalupo A; Biggs J C; Camitta B M; Gale R P; Gordon-Smith E C; Marmont A M
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.
Blood 1992;79(1):269-75.
1991: Marmont A M; Horowitz M M; Gale R P; Sobocinski K; Ash R C; van Bekkum D W; Champlin R E; Dicke K A; Goldman J M; Good R A
T-cell depletion of HLA-identical transplants in leukemia.
Blood 1991;78(8):2120-30.
1989: Champlin R E; Horowitz M M; van Bekkum D W; Camitta B M; Elfenbein G E; Gale R P; Gluckman E; Good R A; Rimm A A; Rozman C
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results.
Blood 1989;73(2):606-13.
1988: Goldman J M; Gale R P; Horowitz M M; Biggs J C; Champlin R E; Gluckman E; Hoffmann R G; Jacobsen S J; Marmont A M; McGlave P B
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.
Annals of internal medicine 1988;108(6):806-14.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Richard Champlin

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Richard Champlin (preview)

All Publications